135 related articles for article (PubMed ID: 38134119)
1. Expression of PTP4A1 in circulating tumor cells and its efficacy evaluation in patients with early- and intermediate-stage esophageal cancer.
Wu J; Wang WX; Zhou Y; Yang DS; Wu ZN; Li X; Tang JM
Medicine (Baltimore); 2023 Dec; 102(51):e36603. PubMed ID: 38134119
[TBL] [Abstract][Full Text] [Related]
2. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
Wang X; Wang Z; Lu WL; Zhao GF
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
[No Abstract] [Full Text] [Related]
3. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
[TBL] [Abstract][Full Text] [Related]
6. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.
Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ
J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the expression of CD24 on circulating tumor cells and prognosis in breast cancer.
Zhou M; Xie P; Chen L; Zhang P; Xu F
Am J Transl Res; 2023; 15(3):1941-1952. PubMed ID: 37056857
[TBL] [Abstract][Full Text] [Related]
11. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
Chen W; Li Y; Yuan D; Peng Y; Qin J
Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
[TBL] [Abstract][Full Text] [Related]
12. Relationship between PRRX1, circulating tumor cells, and clinicopathological parameter in patients with gastric cancer.
Zhang Y; Yao J; Feng J; Wang S; Yang Z; Huang W; Da M
J BUON; 2020; 25(3):1455-1462. PubMed ID: 32862590
[TBL] [Abstract][Full Text] [Related]
13. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer.
Li Y; Wang Z; Fu R; Wang S; Zhang T; Tian X; Yang D
Front Oncol; 2022; 12():828368. PubMed ID: 35387131
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
Hou J; Guo C; Lyu G
Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of circulating tumor cells and disseminated tumor cells in patients with esophageal cancer: a meta-analysis].
Shi XX; An JH; Huang YE; Zhang YZ; Huang ZY; Zou ZN; Chen Q; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):266-273. PubMed ID: 28219875
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PTP4A1 is associated with poor overall survival in non-small cell lung cancer.
Wang T; Shi X; Wang Z; Liu X; Zhang G; Zhu Q; Mi L; Wang R
Int J Clin Exp Pathol; 2018; 11(7):3583-3590. PubMed ID: 31949737
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
19. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis density and growth pattern as independent prognostic factors in advanced esophageal squamous cell carcinoma.
Ooki A; Yamashita K; Kobayashi N; Katada N; Sakuramoto S; Kikuchi S; Watanabe M
World J Surg; 2007 Nov; 31(11):2184-91. PubMed ID: 17721721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
